GlassScriptPhysician profile
Taylor Newman
NPI 1730788944
$15,606.41
in general payments reported to CMS, 2019-2025
36 companies · $3,811 in 2025
The $3,811 reported for 2025 was more than what 98% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,117 · 2022: $2,999 · 2023: $2,908 · 2024: $3,772 · 2025: $3,811.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $10K · Education: $356.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,134.99 |
| Education | $355.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,526.40 | 2021-2025 | |
| Sun Pharmaceutical Industries INC. | $2,018.33 | 2021-2025 | Winlevi, Absorica Ld, Odomzo |
| Novartis Pharmaceuticals Corporation | $1,388.95 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $1,180.53 | 2021-2025 | Dupixent |
| Janssen Biotech, INC. | $1,083.70 | 2021-2025 | Tremfya |
| Genzyme Corporation | $1,077.51 | 2021-2025 | |
| Leo Pharma INC. | $958.18 | 2021-2025 | Adbry, Anzupgo |
| Incyte Corporation | $890.83 | 2021-2025 | Opzelura, Opzelura |
| Lilly USA, LLC | $531.24 | 2021-2025 | Taltz, Ebglyss, Olumiant |
| Galderma Laboratories, L.P. | $495.03 | 2021-2025 | Nemluvio, Aklief, Epsolay |
| Revance Therapeutics, INC. | $468.49 | 2024 | Daxxify |
| Ucb, INC. | $449.21 | 2021-2025 | Bimzelx, Cimzia |
| Amgen INC. | $441.00 | 2021-2025 | Otezla, Otezla |
| Pfizer INC. | $383.98 | 2021-2025 | |
| Journey Medical Corporation | $210.95 | 2023 |
Show all 36 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Taylor Newman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.